妊娠期溃疡性结肠炎治疗经验总结

李猛; 李媛媛; 丁康; 谭妍妍; 杨旭; 方健; 徐翎翎; 张苏闽

doi:10.3969/j.issn.1671-038X.2019.03.17

妊娠期溃疡性结肠炎治疗经验总结

- 南京中医药大学第三附属医院肛肠科, 江苏南京 210000
基金项目:
江苏省自然科学基金资助项目（No：BK20151082）

详细信息

作者简介:
李猛,男,硕士研究生,研究方向:中医外科学

通讯作者: 张苏闽,E-mail:chenmin740@hotmail.com

中图分类号: R574.62

收稿日期: 2018-08-10

Corresponding author: , E-mail: chenmin740@hotmail.com

Received Date: 10 August 2018

摘要

摘要: [目的]有效地控制妊娠期UC患者的病情，减轻药物的毒副作用，帮助患者顺利度过孕产期；[方法]中西医结合、综合调治，包括孕前调理沟通、孕期合理用药、菌群调节、饮食调理、肠内营养以及口服中药等；[结果]已先后诊治妊娠期UC患者40余例，且均顺利生产，在对患者子女的长期随访中未见不良反应的发生。[结论]中西医结合、综合调治的方法治疗妊娠期UC具有一定的价值，可被临床借鉴使用。
- 溃疡性结肠炎 /
- 肠道菌群 /
- 肠内营养

HTML全文

参考文献(29)

[1]	de Silva PS, Hansen HH, Wehberg S, et al.Risk of Ectopic Pregnancy in Women With Inflammatory Bowel Disease:A 22-Year Nationwide Cohort Study[J].Clin Gastroenterol Hepatol, 2018, 16(1):83-89.
[2]	Getahun D, Fassett MJ, Longstreth GF, et al.Association between maternal inflammatory bowel disease and adverse perinatal outcomes[J].J Perinatol, 2014, 34(6):435-440.
[3]	Ban L, Tata LJ, Fiaschi L, et al.Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications[J].Gastroenterology, 2014, 146(1):76-84.
[4]	Bröms G, Granath F, Stephansson O, et al.Preterm birth in women with inflammatory bowel disease-the association with disease activity and drug treatment[J].Scand J Gastroenterol, 2016, 51(12):1462-1469.
[5]	Gaidos JK, Kane SV.Managing IBD Therapies in Pregnancy[J].Curr Treat Options Gastroenterol, 2017, 15(1):71-83.
[6]	Cury DB, Moss AC.Treatment of Crohn's disease in pregnant women:drug and multidisciplinary approaches[J].World J Gastroenterol, 2014, 20(27):8790-8795.
[7]	Khan N, Peters RA, Richardson E, et al.Maternal corticosterone exposure has transgenerational effects on grand-offspring[J].Biol Lett, 2016, 12(11):20160627.
[8]	Skuladottir H, Wilcox A, McConnaughey R, et al.First-trimester nonsystemic corticosteroid use and the risk of oral clefts in Norway[J].Ann Epidemiol, 2014, 24(9):635-640.
[9]	Boyd HA, Basit S, Harpsøe MC, et al.Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes[J].PLoS One, 2015, 10(6):e0129567.
[10]	Ananthakrishnan AN, Cheng A, Cagan A, et al.Mode of Childbirth and Long-Term Outcomes in Women with Inflammatory Bowel Diseases[J].Dig Dis Sci, 2015, 60(2):471-477.
[11]	Lin K, Martin CF, Dassopoulos T, et al.2 Pregnancy Outcomes Amongst Mothers With Inflammatory Bowel Disease Exposed to Systemic Corticosteroids:Results of the PIANO Registry[J].Gastroenterol, 2014, 146(5):S1-S1.
[12]	Nørgȃrd B, Pedersen L, Fonager K, et al.Azathioprine, mercaptopurine and birth outcome:a population-based cohort study[J].Aliment Pharmacol Ther, 2003, 17(6):827-834.
[13]	Lagarce L, Bernard N, Carlier P, et al.Pregnancy outcomes after preconceptional exposure to methotrexate for ectopic pregnancy[J].Therapie, 2016, 71(4):389-394.
[14]	Bröms G, Granath F, Stephansson O, et al.Preterm birth in women with inflammatory bowel disease-the association with disease activity and drug treatment[J].Scand J Gastroenterol, 2016, 51(12):1462-1469.
[15]	Kanis SL, de Lima-Karagiannis A, de Boer NKH, et al.Use of Thiopurines During Conception and Pregnancy Is Not Associated With Adverse Pregnancy Outcomes or Health of Infants at One Year in a Prospective Study[J].Clin Gastroenterol Hepatol, 2017, 15(8):1232-1241.
[16]	Mozaffari S, Abdolghaffari AH, Nikfar S, et al.Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs:A systematic review with meta-analysis[J].Hum Exp Toxicol, 2015, 34(5):445-459.
[17]	Westbrook RH, Yeoman AD, Agarwal K, et al.Outcomes of pregnancy following liver transplantation:The King's College Hospital experience[J].Liver Transpl, 2015, 21(9):1153-1159.
[18]	Götestam Skorpen C, Hoeltzenbein M, Tincani A, et al.The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation[J].Ann Rheum Dis, 2016, 75(5):795-810.
[19]	McConnell RA, Mahadevan U.Use of Immunomodulators and Biologics Before, During, and After Pregnancy[J].Inflamm Bowel Dis, 2016, 22(1):213-223.
[20]	Mahadevan U, Vermeire S, Wolf DC, et al.DOP024 Pregnancy outcomes after exposure to certolizumab pegol:Results from safety surveillance[J].Gastroenterol, 2015, 148(4):S858-S859.
[21]	Androulakis I, Zavos C, Christopoulos P, et al.Safety of anti-tumor necrosis factor therapy during pregnancy in patients with inflammatory bowel disease[J].World J Gastroenterol, 2015, 21(47):13205-13211.
[22]	de Lima A, Zelinkova Z, van der Ent C, et al.Tailored anti-TNF therapy during pregnancy in patients with IBD:maternal and fetal safety[J].Gut, 2016, 65(8):1261-1268.
[23]	Julsgaard M, Christensen LA, Gibson PR, et al.Concentrations of Adalimumab and Infliximab in Mothers and Â Newborns, and Effects on Infection[J].Gastroenterol, 2016, 151(1):110-119.
[24]	Ron S, Shai F, Ron M.Revised Estimates for the Number of Human and Bacteria Cells in the Body[J].PLoS Biology, 2016, 14(8):e1002533.
[25]	张永利, 申妮.溃疡性结肠炎患者肠道菌群的变化特征[J].河北医药, 2018, 40(7):96-99.
[26]	Rossi E, Di MS, Firenzuoli F, et al.Add-On Complementary Medicine in Cancer Care:Evidence in Literature and Experiences of Integration[J].Medicines (Basel), 2017, 4(1):E5.
[27]	Jayakar JP, Alter DA.Music for anxiety reduction in patients undergoing cardiac catheterization:A systematic review and meta-analysis of randomized controlled trials[J].Complement Ther Clin Pract, 2017, 28:122-130.
[28]	白焕焕.肠内营养对溃疡性结肠炎患者的疗效评价及生活质量评估[D].吉林大学, 2016.
[29]	中国中西医结合学会消化系统疾病专业委员会.溃疡性结肠炎中西医结合诊疗共识意见(2017年)[J].中国中西医结合消化杂志, 2018, 26(2):105-111, 120.